Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
This piece explains what sequence of returns risk is in retirement, why it matters for retirement income, and how to interpret its effects on portfolios.
26,990 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Cardano's governance changes are triggering uncertainty. This article explains why cardano's founder predicts hard ti...
A prominent asset manager has quietly ramped up its Bitcoin exposure, even as its massive stash remains underwater. T...
June brought a sharp pullback for software names, and figma stock lost june as AI disruption fears collided with rota...
Bitcoin faced a rough weekend, dipping nearly 5% as macro signals collided with crypto headlines. This guide unpacks ...
Kinsale Capital is carving a niche in the specialty insurance market. This article breaks down why it might be a stro...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...
Oklo stock has faced big swings, but analysts see a potential upside. This guide breaks down what the projection to $...
NuScale Power faces a high-stakes decade as regulators, financiers, and utilities weigh SMR potential. This article l...
NuScale Power stock has been under pressure as investors digest macro concerns and regulatory headwinds. This guide b...
Seasonal 13F filings shed light on big moves by top money managers. This article breaks down a notable shift: billion...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...